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A young soccer player was diagnosed with myositis
ossiﬁcans 6 weeks after a muscle strain in the right
thigh. Radiographic and sonographic investigations
initially helped to conﬁrm diagnosis and later supported
clinical improvement. We present our approach to the
case and discuss pathophysiology, prevention and
treatment of this rare condition.
BACKGROUND
Myositis ossiﬁcans (MO) is a rare disorder charac-
terised by non-neoplastic heterotopic bone forma-
tion in soft tissue and skeletal muscle.1 Three types
can be differentiated: MO progressiva (hereditary
and severe generalised form), MO without history
of trauma (associated with burns, haemophilia and
neurological disorders) and MO circumscripta or
traumatica (either related to a direct blow or
repeated minor trauma).1 The latter is the most
common, representing 60–75% of all cases.2
Although it can be seen at any age, the highest inci-
dence is reported in adolescents and young adults.1
MO traumatica (MOT) mainly affects extremities,
most often the anterior thigh and arm.3 The
clinical presentation encompasses a painful soft
tissue mass usually with no inﬂammatory signs.
The diagnosis of this condition may be difﬁcult and
requires radiological and/or histological ﬁndings.
To accurately interpret these, one must be familiar
with its aetiopathogenesis—MOT is essentially a
proliferative mesenchymal response to an initiating
injury to the soft tissue that leads to localised ossiﬁ-
cation.3 In the ﬁrst week after injury, proliferative
ﬁbroblastic cells are prominent. As maturation
proceeds, a typical zonal pattern develops with
three distinct zones: the centre, characterised by
rapid proliferating ﬁbroblasts; the intermediate
zone, consisting of osteoblasts with immature
osteoid formation and the periphery, composed of
mature bone well separated from the surrounding
tissue by myxoid ﬁbrous tissue. Around the third to
fourth week, calciﬁcations appear inside the mass.
By the sixth to eighth week, a well-organised
cortical bone with cortex and marrow space can be
seen at the periphery. The maturation process
proceeds so that, by 6 months, the bone is indistin-
guishable from the normal skeleton.4 5 As a self-
limited condition, in most cases, conservative treat-
ment with clinical and radiological follow-up is
usually enough.3 Surgical excision is an exceptional
option when function is impaired or the mass is
unusually large or painful.6
We present a case of a soccer player who devel-
oped MOT following a quadriceps femoris strain
and an early return to practice. To the best of our
knowledge, this is one of the few case reports of
MOT secondary to an indirect muscle injury. We
aim to emphasise the importance of recognising
signiﬁcant muscle injuries and to adjust rehabilita-
tion and return-to-play schemes according to the
extent of the lesion.
CASE PRESENTATION
A 25-year-old Caucasian man with anterior thigh
pain was referred to the clinic. The patient recalled
a muscle strain 6 weeks before, when sprinting to
get to the ball at the end of a soccer match. He had
to be substituted due to intense pain and spent the
two following weeks being treated by the team’s
physiotherapist. Treatment consisted mostly of
cryotherapy and massage. He resumed training but
after 1 week had to stop due to increased pain, and
a decrease in range of motion (ROM) and function
of his right leg. The patient was an amateur soccer
player with 10 h/week spent between training and
competition. He denied having suffered a contu-
sion to his right thigh in the previous weeks and
also denied having any relevant personal or family
history, constitutional symptoms or drug use.
Physical examination at the clinic revealed a right
thigh perimeter 2 cm larger than the contralateral.
He had limited ROM of his right knee, achieving
no more than 90° ﬂexion with preserved extension.
Tenderness along the medial third of the thigh
along with pain on passive stretching, and on static
and dynamic quadriceps contraction, was evident.
The patient had no inﬂammatory signs and neuro-
vascular examination was unremarkable.
INVESTIGATIONS
Radiographs (ﬁgures 1 and 2) showed new bone
adjacent to the proximal 2/3 of the right femur.
A bedside ultrasound examination (ﬁgure 3)
revealed a hyperechoic reﬂection of the calciﬁed
surface with posterior attenuation located at the
rectus femoris myotendinous junction. Biarticular
muscles (such as this) are commonly injured at this
location in strain injuries. An MRI was performed
in order to exclude non-benign causes of a soft
tissue mass. It identiﬁed a mass located in the prox-
imal 1/3 of rectus femoris muscle with character-
istics compatible with MOT.
TREATMENT
The patient was instructed to use crutches, with
partial weight-bearing allowed for 10 days. Static
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cryotherapy was performed and he received a prescription for
etoricoxib 60 (1 pill/day for 2 weeks) and an elastic bandage. A
rehabilitation programme was initiated, which in the ﬁrst
4 weeks included quadriceps work (static contraction 0–30°; 25
and 45 Hz electrical stimulation), static stretching, intermittent
ultrasound (1.5 Hz for 10 min) and manual therapy. Over the
following 4 weeks, the (now asymptomatic) patient started
closed kinetic chain muscular strengthening, proprioceptive
training, deep transverse massage and aerobic reconditioning
with cycloergometer (55% maximum heart rate; HRmax).
Protein supplementation with branched-chain amino acids
(BCAA; 1 g/kg) was started during this period. Between the 8th
and 12th week, eccentric work of quadriceps and hamstrings
was added alongside jogging and some on-ﬁeld activities. From
the 12th week on, the patient was allowed to begin
sport-speciﬁc training, and by the 24th week, he started compet-
ing without restrictions.
OUTCOME AND FOLLOW-UP
Follow-up after 40 weeks revealed an asymptomatic patient.
Ultrasound and X-ray showed marked decrease in the number
and volume of calciﬁcations.
DISCUSSION
Four pre-requisites (previous conditions) seem to be necessary
for MOT formation: an initial traumatic injury, the secretion of
a protein by injured tissue or inﬂammatory cells, a reservoir of
not fully committed mesenchymal cells and a favourable envir-
onment to continued heterotopic bone deposition.2
Most case reports identify contusion as the initial injury. To the
best of our knowledge, this report is one of the few where strain
was the inciting event.7–9 The relevance of this feature remains
unknown and might not be considerable since the following
event (intramuscular haematoma formation) is already a
common step in the cascade of events.10 11 The patient restarted
training only 2 weeks after muscle injury. Premature return to
activity is referred to by King11 as a main risk factor for MOT
development. He relies on the work developed with West Point
cadets, where the incidence of MOT following thigh contusions
decreased from 20% (in 1973) to 9% (in 1991).11 A possible
explanation could be an improvement in acute phase healthcare
and optimisation of recovery periods. Prescription of non-
steroidal anti-inﬂammatory drugs (NSAIDs) is often regarded as
a prevention strategy for MOT. In fact, NSAIDs have shown
some efﬁcacy in MO prevention following spinal cord injury and
joint replacement,12 leading to an extrapolation of this beneﬁt to
MOT cases. Nonetheless, ‘state of the art’ treatment of muscle
injuries no longer includes NSAIDs because the COX-2 pathway
Figure 2 Calciﬁcations along the medial border of the proximal
femur (lateral view).
Figure 1 Calciﬁcations along the medial border of the proximal
femur (anteroposterior view).
Figure 3 Ultrasound showing hyperechoic reﬂection of the calciﬁed
surface with posterior attenuation.
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is seen as essential during early stages of skeletal muscle regener-
ation.13 Hence, when weighing the ability to prevent the rare
MOT and reduce pain in short-term against long-term deﬁcit in
force production and muscle repair, we tend to choose the
latter.14 In the future, a better understanding of risk factors for
MOT’s may allow differentiation of a subgroup in which the
overall risk of developing this condition is high enough to
deserve NSAIDs prophylaxis. Research focused on ﬁnding other
risk factors has led to inconclusive/equivocal results.12
MOT diagnosis must be considered in the context of
a muscle injury, especially when the symptoms intensify
2–3 weeks after the trauma. Additional clinical suspicion is
warranted if the area becomes more indurated and loss of ROM
is observed. Imaging studies differ in their sensitivity and speciﬁ-
city according to the phase of the maturation process.15 While
ultrasound is able to detect the early soft tissue changes of MO,
conventional radiography and CT conﬁrm the existence of het-
erotopic bone formation and may display speciﬁc patterns of
MOT.15 MRI is the technique of choice to evaluate soft tissue
lesions, which makes it useful in the differential diagnosis with
neoplasms.15 The differential diagnosis of MOT includes malig-
nant tumours such as lymphoma, osteosarcoma and rhabdomyo-
sarcoma.12 In this patient, 6 weeks after the inciting injury,
ultrasound and X-ray revealed ﬁndings compatible with MOT.
He denied constitutional symptoms (chills, fever or weight loss)
and his laboratory tests (white cell count; erythrocyte sedimen-
tation rate and C reactive protein; alkaline phosphatase levels;
calcium levels; creatine kinase levels) were all within normal
values. MRI conﬁrmed our strong clinical suspicion that this
was an MOT case. Radiography and ultrasound repeated at the
40th week showed marked improvement. The time to radio-
logical and clinical resolution is in line with some of the well-
resulting case reports found in the literature.16 In complicated
cases, symptoms and radiological ﬁndings may last more than a
year. Whether this difference is due to treatment or to local/sys-
temic factors remains unknown. Biopsy was not performed, as it
is only required in atypical cases, in young patients with no pre-
vious trauma or when imaging studies are inconclusive.2
Radiation therapy can be used to reduce size and accelerate
the lesion’s maturation, especially when planning surgery.17
Given the favourable evolution, we found it unnecessary.
Bisphosfonate therapy is another option often mentioned in the
literature; we, however, did not explore it. Its inhibitory effect
on bone formation is limited to the crystallisation process,
leaving bone matrix formation unaffected. This means that,
after cessation of treatment, the matrix resumes uninhibited
mineralisation. It therefore follows that an early diagnosis is of
utmost importance and treatment with bisphosfonate has to be
continued for at least 6 months.12 Surgery was not advised since
there was no signiﬁcant pain or functional limitation. The deci-
sion to give protein supplements was made according to recent
evidence suggesting that exercise combined with BCAA
improves muscle repair and growth in athletes.18
Treatment of MOT in the acute phase is mainly conservative,
designed to control pain and inﬂammation, and later to stimu-
late ﬂexibility, strength and ﬁtness status.
Learning points
▸ Myositis ossiﬁcans is rarely reported after strain injuries.
▸ Optimisation of time to return to practice and rehabilitation
programmes might be the key for prevention of myositis
ossiﬁcans.
▸ A soccer player was able to return to competition after
24 weeks of conservative treatment.
▸ Ultrasound evidence of calciﬁcations persists long after
clinical resolution.
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